Ronald Kirk Huntsman - Dec 23, 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Stock symbol: VVOS
Transactions as of: Dec 23, 2022
Transactions value $: $242,000
Form type: 4
Date filed: 12/28/2022, 08:45 PM
Previous filing: Jun 3, 2022
Next filing: Jun 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VVOS	Common Stock	Purchase	$10K	+20K	+72.73%	$0.50	47.5K	Dec 23, 2022	Direct	F1
holding	VVOS	Common Stock						1.74M	Dec 23, 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VVOS	Stock Option (Right to Buy)	Award	$160K	+333K		$0.48	333K	Dec 23, 2022	Common Stock	333K	$0.48	Direct	F2
transaction	VVOS	Stock Option (Right to Buy)	Award	$72K	+150K	+45%	$0.48	483K	Dec 23, 2022	Common Stock	483K	$0.48	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F2	333,334 fully vested stock options granted on December 23, 2022.
F3	150,000 stock options granted on December 23, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through December 23, 2026.